Telmisartan Tablets recalled over labeling errors
- Recall date
- March 24, 2021
- Source
- U.S. Food & Drug Administration (FDA) — recall announcement
- Official notice title
- Alembic Pharmaceuticals, Inc. recalls Alembic — Telmisartan Tablets, USP, 20 mg
- Brand / firm
- Alembic Pharmaceuticals, Inc., Alembic
Why it was recalled
Incorrect Product Strength on Label — Mislabeling
What was recalled
Telmisartan Tablets, USP, 20 mg
Read the official recall notice →
Get recall alerts
Free email alert whenever Alembic Pharmaceuticals, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Alembic Pharmaceuticals, Inc., Alembic